Bachelor of Science (BS), Ohio University, 2023, Translational Health
Background: Diabetes mellitus is a collection of chronic diseases characterized by
hyperglycemia, or high blood sugar. Chronic health complications can arise from this disease,
including macrovascular complications such as cardiovascular disease that can result in
myocardial infarction and/or stroke, microvascular complications including retinopathy,
nephropathy, and neuropathy, as well as psychological complications such as depression,
anxiety, and diabetes distress. Despite the existence of many effective glycemic control agents,
rates of diabetes incidence and mortality continue to rise, prompting the investigation of novel,
multi-action therapeutics. Cannabidiol (CBD) is a non-intoxicating phytocannabinoid derived
from the Cannabis sativa (marijuana) plant that has widespread physiological effects, an
excellent safety profile, and growing consumer interest within the US. Methods: A
comprehensive, scoping review of the literature was conducted in order to organize and assess
evidence for CBD's ability to manage, prevent, and or delay the onset of diabetes and diabetic
complications. The research databases PubMed, Embase, Cochrane Library, and SCOPUS were
searched. Results: A total of 1,324 articles were assessed against relevant inclusion and
exclusion criteria, resulting in 40 included articles. The majority of included articles reported
CBD improved glycemic measures associated with diabetes, yet this was not an overwhelming
consensus. CBD showed mixed therapeutic effects in diabetic complications. This scoping
review provides a broad review of studies with heterogenous designs and methods. Gaps in the
scientific literature were discovered, including deficits in human in vivo research evaluating the
therapeutic effects of CBD in diabetes and diabetic complications, as well as conflicting
experimental results. Conclusions: More research, especially in diabetic human subjects, is
needed to elucidate the therapeutic effects of CBD in diabetes (open full item for complete abstract)
Committee: Cheryl Howe (Committee Chair); Yuanjie Mao (Advisor)
Subjects: Alternative Medicine; Biomedical Research; Endocrinology